Every earnings call for CHAMBLFERT — management tone, guidance, KPIs and promise tracking, quarter by quarter.
CHAMBLFERT · 7 transcripts · Chemicals · latest Q4 FY26Revenue (Q4 FY26) ₹2,785 cr (+14% YoY); EBITDA (Q4 FY26) ₹255 cr (+56% YoY); EBITDA Margin (Q4 FY26) 9.16%. Q4 FY26 Revenue from operations grew 14% YoY to ₹2,785 crores.
Read full transcript & analysisQ3 Revenue from Operations ₹5,898 cr (+20% YoY); Q3 EBITDA ₹821 cr (+6% YoY); Q3 EBITDA Margin 13.92%. Q3 FY26 Revenue from operations grew 20% YoY to INR 5,898 crores.
Read full transcript & analysisRevenue ₹6,413 cr (+48% YoY); EBITDA ₹882 cr (+6% YoY); PAT ₹602 cr (+20% YoY). Standalone Revenue for Q2 FY26 stood at ₹6,413 crore, a significant 47.6% YoY increase from ₹4,346 crore.
Read full transcript & analysisStandalone Revenue ₹5,698 cr; Standalone EBITDA ₹929 cr; Consolidated PAT ₹549 cr (+23% YoY). Consolidated PAT grew 23% YoY to ₹549 crore, while Standalone PAT rose 16% to ₹638 crore.
Read full transcript & analysisRevenue (Standalone Q4) ₹2,449 cr; EBITDA (Full Year) ₹2,838 cr (+17% YoY); PAT (Full Year) ₹1,657 cr (+24% YoY). Full-year FY25 PAT grew 24% YoY to ₹1,657 crore, while EBITDA rose 17% to ₹2,838 crore.
Read full transcript & analysisEBITDA (Standalone) ₹843 cr (+16% YoY); PAT (Standalone) ₹505 cr (+25% YoY). Standalone EBITDA reached ₹843 crores, representing a 16% YoY growth.
Read full transcript & analysisStandalone EBITDA ₹834 cr (+20% YoY); Standalone PAT ₹500 cr (+34% YoY). Consolidated PAT grew 41% YoY to ₹536 crore in Q2 FY25.
Read full transcript & analysis